MabQuest SA has a total of 17 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AMGEN RES MUNICH GMBH, AMGEN RES (MUNICH) GMBH and OGD2 PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Pantaleo Giuseppe | 17 |
#2 | Fenwick Craig | 17 |
Publication | Filing date | Title |
---|---|---|
CA3012075A1 | Immunological reagents | |
US2017166642A1 | Immunological reagents | |
WO2016020856A2 | Immunological reagents binding to pd-1 |